Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Head and Neck Oncology
  •  Neoadjuvant Therapy
  •  Haemato-Oncology
  •  Immunotherapy
  •  Breast Cancer
  •  Pancreatic Cancer
  •  Kidney Cancer
  •  Thoracic Oncology


Citation: Clin Oncol. 2023;8(1):2013.DOI: 10.25107/2474-1663.2013

Dual TKI Therapy in Acquired ALK Gene Fusion as Mechanism of Resistance to Osimertinib in EGFR-Mutant Advanced NSCLC

Portugal GM, Sousa AC2 and Alves P

Hospital Pulido Valente, Centro Hospitalar Universitário Lisboa Norte (CHULN), Portugal
GenoMed—Diagnosticos De Medicina Molecular, S.A., Avenida Professor Egas Moniz, Portugal

*Correspondance to: Portugal GM 

 PDF  Full Text Case Report | Open Access


Epidermal Growth Factor Receptor (EGFR) gene somatic activating mutations account for approximately 20% of lung adenocarcinomas. Tyrosine Kinase Inhibitors (TKIs) are the standard therapy of advanced Non-Small Lung Cancer (NSCLC) harboring EGFR gene mutations. Response to TKI is inevitably followed by acquired resistance and disease progression. The mechanisms of resistance to EGFR-TKIs are remarkably heterogeneous. In recent years, the mutual exclusive possibility of EGFR mutations and ALK rearrangements has been questioned. In fact, several reports show a prevalence of 1.6% of these concomitant mutations in advanced NSCLC with only 0.13% of EGFR-mutated NSCLC developing TKI resistance by acquired ALK translocation. Inhere, a case of an acquired ALK rearrangement following the development of resistance to Osimertinib treatment is reported as well as the efficacy and safety of dual TKI therapy.


Cite the Article:

Portugal GM, Sousa AC, Alves P. Dual TKI Therapy in Acquired ALK Gene Fusion as Mechanism of Resistance to Osimertinib in EGFR-Mutant Advanced NSCLC. Clin Oncol. 2023;8:2013..

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Regional Recurrence of Breast Cancer in Ipsilateral Intramammary Lymph Node Six Months after Breast Conserving Surgery
 Abstract  PDF  Full Text
Gene Polymorphisms and Gene Expression Profiles as Potential Predictors of Survival Outcomes in Ovarian Cancer: Systematic Review and Meta-Analysis of Pharmacogenetic/Genomic and Microarray Data
 Abstract  PDF  Full Text
View More...